Nobel Biocare USAPress Releases

Integration Streamlines Prosthetic Workflow for Dental Specialists

The initial allocation of seats for Nobel Biocare’s 2016 Global Symposium in New York has been filled. Nobel Biocare will welcome over 2,000 dental professionals to the event, which takes place June 23–26 at the iconic Waldorf Astoria Hotel in New York City, US. 

Given the high demand, a limited number of additional places have been made available, though they are expected to fill up quickly. Those who wish to attend the event should visit nobelbiocare.com/global-symposium-2016 or...

As of January 1, Hans Geiselhöringer has taken over as President of Nobel Biocare. The appointment was made to strengthen the organization around its strategic goals.

Since 2011 Hans Geiselhöringer has served as Executive Vice President of Global Research, Products and Development, shaping a highly competitive product and innovation pipeline. Prior to that he was Executive Vice President Global Marketing and Products from 2010–2011 and Head of NobelProcera and Guided Surgery from...

Nobel Biocare has always been and continues to be in full compliance with the FDA regulation and NADL recommendations when producing individualized implant prosthetics. The recent communication from NADL with an important FDA Alert regarding the use of CAD/CAM for in-lab milling of implant abutments does not affect any Nobel Biocare products. Our NobelProcera manufacturing facility in Mahwah, New Jersey is registered as a Medical Device Manufacturer. In addition we have FDA 510(k) clearance on all...

• New options for NobelProcera® Abutments on Biomet 3i™, Camlog® and Zimmer® implant platforms

• More restorative flexibility with NobelProcera® Implant Bars on Straumann® implant platforms

• Announcing direct access to unrivaled products with upcoming NobelProcera® 2G Scanner

• New partnership with 3Shape™ will offer open access to NobelProcera® Abutments

• Expert LMT panel discussion and industry-leading speakers focus on major lab and CAD/CAM...